Khalid Matalka
Matalka's Scientific Writing, OncoTherapeutica, Inc., American University of Madaba
About
Professor Khalid Matalka received his BSc and MSc in Medical Technology in 1986 and 1988 from Yarmouk University, Jordan, and the University of Wisconsin-Milwaukee, USA, respectively. Then he received his PhD. in Pathology (Immunology and Cancer therapy) from Ohio State University, USA, in 1992. After finishing his PhD., Dr. Matalka joined Harvard Medical School as a Postdoctoral fellow till 1994. He is an American Board Certified as Specialist in Immunology (SI (ASCP)) and a member at the American Society for Cancer Research since 1994.
Dr. Matalka moved to Jordan in 1994 and, in Feb 1995, joined the Faculty of Pharmacy and Medical Sciences at the University of Petra (formerly Jordan University for Women) as an Assistant Professor. He was promoted to an Associate Professor in 1999, and then to Professor in 2004. Prof. Matalka was promoted to be the Dean of the Faculty of Pharmacy and Medical Sciences in 2006 till 2009. In 2009-2011, he joined King Hussein Institute for Biotechnology and Cancer as the Director for Infrastructure Research. In 2011, Prof. Matalka became a consultant for the Deanship of Research at the University of Petra. In 2012, he was chosen by the University president to be the director of a new research center (Petra University Pharmaceutical Center). In 2014, Prof. Matalka joined the American University of Madaba and held the Chairman of the Department of Medical Laboratories and then as the Dean of Health Sciences (consisting of three departments: Medical Laboratories, Nutrition and Dietetics, and Pharmacy) at the American University of Madaba. In 2016, he joined a pharmaceutical startup company named OncoTherapeutica, as a Chief Biologist. While there, Prof. Matalka was developing new potential drugs for the treatment of prostate cancer and melanoma.
Prof. Matalka has 63 publications in peer-reviewed international journals, and he is an Associate Editor of two and a member of the editorial board of several international journals. Prof. Matalka is known as an international reviewer in the fields of Cancer therapy, Immunomodulation, and Ethnopharmacology.
Because of his passion for scientific and medical writing, Prof. Matalka recently established a scientific writing consultation (https://matalkascientificwriting.com). He believes that scientific writing is a hybrid of compelling science and art of presentation while maintaining a positive mindset, focused with a purpose, and always striving for significant outcomes.
Employment
-
Matalka's Scientific Writing Founder2020 - Present
-
OncoTherapeutica, Inc. Chief Biologist2016 - 2020
-
American University of Madaba Dean, Chairman, & Professor2014 - 2016
-
University of Petra Director, Dean, Professor1995 - 2014
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (58)
- Formulation and Manufacturing Process of Softgel Capsules Containing Common Butterbur Root Extract: A Stability Study and Method of Analysis Save
- Flavonoid- and polyphenol-rich natural cough syrup from licorice, marshmallow, and anise extracts: An efficacy and tolerability study Save
- Awareness and attitude towards complementary and alternative medicine among pharmacy- and non-pharmacy- undergraduate students: A cross-sectional study from Jordan Save
- Novel secondary pyridinyl amides: Synthesis, in vitro antiproliferative screenings, and molecular docking studies Save
- Impact of Pomegranate Juice on the Pharmacokinetics of CYP3A4- and CYP2C9-Mediated Drugs Metabolism: A Preclinical and Clinical Review Save
- The Prevalence of Overweight and Obesity Among Women in Jordan: A Risk Factor for Developing Chronic Diseases. Save
- Age of Natural Menopause Among Jordanian Women and Factors Related to Premature and Early Menopause. Save
- Biomolecular docking, synthesis, crystal structure, and bioassay studies of 1-[4-(2-chloroethoxy)phenyl]-5-[4-(methylsulfonyl)phenyl]-1H-tetrazole and 2-(4-(5-(4-(methylsulfonyl)phenyl)-1H-tetrazol-1-yl)phenoxy)ethyl nitrate Save
- Pleiotropic anticancer properties of scorpion venom peptides: Rhopalurus princeps venom as an anticancer agent Save
- A functional food mixture “protector” reinforces the protective immune parameters against viral flu infection in mice Save